Literature DB >> 6600741

The beta-lactamase stability of amoxycillin with the beta-lactamase inhibitor, clavulanic acid.

C Reading, T Farmer, M Cole.   

Abstract

The stability of low concentrations of amoxycillin in the presence of clavulanic acid (potassium salt) was determined for a wide range of clinically important beta-lactamases including the staphylococcal and TEM plasmid mediated enzymes. Even with enzyme preparations which completely hydrolysed the amoxycillin within a minute, clavulanic acid provided significant protection. The time course of the protection of amoxycillin reflected the time dependent action of clavulanic acid.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600741     DOI: 10.1093/jac/11.1.27

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

Review 1.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

2.  Clavulanic acid does not affect convulsions in acute seizure tests in mice.

Authors:  Maciej Gasior; Katarzyna Socała; Dorota Nieoczym; Piotr Wlaź
Journal:  J Neural Transm (Vienna)       Date:  2011-06-03       Impact factor: 3.575

Review 3.  Antibiotic resistance breakers: current approaches and future directions.

Authors:  Mark Laws; Ali Shaaban; Khondaker Miraz Rahman
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.